The Enterprise Value as of December 2024 (TTM) for Bionano Genomics, Inc. (BNGO) is 34.30M

According to Bionano Genomics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 34.30M. This represents a change of -55.52% compared to the average of 77.12M of the last 4 quarters.

Bionano Genomics, Inc. (BNGO) Historical Enterprise Value (quarterly & annually)

How has BNGO Enterprise Value performed in the past?

The mean historical Enterprise Value of Bionano Genomics, Inc. over the last ten years is 221.78M. The current 34.30M Enterprise Value has changed 1.45% with respect to the historical average. Over the past ten years (40 quarters), BNGO's Enterprise Value was at its highest in in the March 2021 quarter at 1.79B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.

Bionano Genomics, Inc. (BNGO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bionano Genomics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bionano Genomics, Inc. (BNGO) Average Enterprise Value

How has BNGO Enterprise Value performed in the past?

The current Enterprise Value of Bionano Genomics, Inc. (BNGO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Bionano Genomics, Inc. (BNGO) Enterprise Value vs. Peers

How is BNGO’s Enterprise Value compared to its peers?

Bionano Genomics, Inc.’s Enterprise Value is less than Intuitive Surgical, Inc. (188.86B), greater than Innovative Eyewear, Inc. (9.43M), less than Stereotaxis, Inc. (192.89M), less than NEXGEL, Inc. (34.39M), greater than Microbot Medical Inc. (16.50M), less than STAAR Surgical Company (1.11B), less than Envista Holdings Corp (3.84B), greater than G Medical Innovations Holdings Ltd (3.60M), less than Becton, Dickinson and Company (84.21B), less than West Pharmaceutical Services, Inc. (23.82B), less than ResMed Inc. (34.45B), greater than Wearable Health Solutions, Inc. (2.55M), greater than BioLife Sciences Inc. (156.68K), greater than Psykey, Inc. (1.05M), greater than Predictive Oncology Inc. (4.29M), greater than Sharps Technology, Inc. (3.47M), greater than GlucoTrack, Inc. (6.05M), greater than Meihua International Medical Technologies Co., Ltd. (2.36M),

Build a custom stock screener for Bionano Genomics, Inc. (BNGO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bionano Genomics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bionano Genomics, Inc. (BNGO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bionano Genomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.